Overview
- The executive order, which Mr. Trump signed on Aug. 10, directs federal agencies to narrow the routine childhood vaccine list, promote spacing of doses, and pursue splitting the combined MMR vaccine into separate measles, mumps and rubella shots.
- The order instructs the Justice Department to pressure or sue states that do not adopt the administration’s preferred exemption policies or revise school‑entry requirements.
- Major medical groups, public‑health experts and patient advocates have condemned the move as unscientific and say spacing or unbundling vaccines risks increasing missed doses and worsening ongoing measles outbreaks.
- Industry and former regulators note that no licensed single‑disease measles, mumps or rubella vaccines are currently produced for the U.S. market and that redeveloping, producing and gaining FDA approval for separate products would likely take years and substantial investment.
- The order is a federal directive but has not changed state school‑entry laws; implementation would require CDC/ACIP rulemaking, manufacturer action and FDA approvals, and multiple states and medical coalitions are preparing legal challenges.